Major trial launches for first chikungunya vaccine
⭐️ VACCINE ⭐️
Not yet recruiting
This study tests an experimental vaccine to prevent chikungunya, a mosquito-borne virus that causes fever and joint pain. About 6,144 adolescents and adults will receive either the vaccine or a placebo. The goal is to see if the vaccine can stop the disease and reduce long-term j…
Phase: PHASE3 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC